Royce & Associates LP Apyx Medical Corp Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Apyx Medical Corp stock. As of the latest transaction made, Royce & Associates LP holds 2,582,490 shares of APYX stock, worth $4.05 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,582,490

Previous 2,497,223 3.41%

Holding current value

$4.05 Million

Previous $3.35 Million 4.3%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$1.01 - $1.46 $86,119 - $124,489	85,267 Added 3.41%	2,582,490 $3.2 Million
Q2 2024 Aug 13, 2024	BUY	$1.26 - $1.66 $76,310 - $100,536	60,564 Added 2.49%	2,497,223 $3.35 Million
Q1 2024 May 13, 2024	BUY	$1.25 - $2.71 $347,198 - $752,726	277,759 Added 12.87%	2,436,659 $3.31 Million
Q4 2023 Feb 12, 2024	BUY	$1.49 - $3.25 $222,457 - $485,225	149,300 Added 7.43%	2,158,900 $5.66 Million
Q3 2023 Nov 09, 2023	BUY	$3.07 - $6.2 $1.25 Million - $2.52 Million	406,624 Added 25.37%	2,009,600 $6.43 Million
Q2 2023 Aug 07, 2023	BUY	$2.75 - $7.59 $400,837 - $1.11 Million	145,759 Added 10.0%	1,602,976 $8.06 Million
Q1 2023 May 04, 2023	BUY	$2.45 - $3.59 $1.61 Million - $2.36 Million	658,749 Added 82.5%	1,457,217 $4.2 Million
Q4 2022 May 23, 2023	SELL	$1.4 - $5.02 $922,248 - $3.31 Million	-658,749 Reduced 45.21%	798,468 $1.87 Million
Q4 2022 Feb 13, 2023	SELL	$1.4 - $5.02 $120,119 - $430,715	-85,800 Reduced 9.7%	798,468 $1.87 Million
Q3 2022 Nov 03, 2022	BUY	$4.49 - $10.83 $1.86 Million - $4.49 Million	415,000 Added 88.44%	884,268 $3.97 Million
Q2 2022 Aug 04, 2022	BUY	$3.11 - $7.5 $21,148 - $51,000	6,800 Added 1.47%	469,268 $2.75 Million
Q1 2022 May 05, 2022	SELL	$5.87 - $13.13 $68,092 - $152,308	-11,600 Reduced 2.45%	462,468 $3.02 Million
Q4 2021 Feb 07, 2022	SELL	$12.15 - $17.4 $847,243 - $1.21 Million	-69,732 Reduced 12.82%	474,068 $6.08 Million
Q3 2021 Nov 10, 2021	SELL	$8.79 - $13.96 $131,850 - $209,400	-15,000 Reduced 2.68%	543,800 $7.53 Million
Q3 2020 Nov 12, 2020	BUY	$4.38 - $5.47 $897,462 - $1.12 Million	204,900 Added 57.9%	558,800 $2.63 Million
Q2 2020 Aug 07, 2020	SELL	$2.87 - $5.83 $106,565 - $216,473	-37,131 Reduced 9.5%	353,900 $1.96 Million
Q1 2020 May 12, 2020	SELL	$3.24 - $8.51 $391,340 - $1.03 Million	-120,784 Reduced 23.6%	391,031 $1.4 Million
Q4 2019 Feb 06, 2020	BUY	$6.29 - $8.46 $288,711 - $388,314	45,900 Added 9.85%	511,815 $4.33 Million
Q3 2019 Nov 13, 2019	BUY	$6.3 - $7.9 $714,420 - $895,860	113,400 Added 32.17%	465,915 $3.15 Million
Q2 2019 Aug 12, 2019	SELL	$3.64 - $6.95 $1.47 Million - $2.8 Million	-402,900 Reduced 53.33%	352,515 $2.37 Million
Q1 2019 May 09, 2019	BUY	$6.31 - $8.75 $4.77 Million - $6.61 Million	755,415 New	755,415 $4.77 Million

Others Institutions Holding APYX

# of Institutions

Shares Held

14.3M

Call Options Held

353K

Put Options Held

1.6K

View Full List

About Apyx Medical Corp

Ticker APYX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 34,573,000
Market Cap $54.3M
Description
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...

More about APYX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Apyx Medical Corp Transaction History